× Didn't find what you were looking for? Ask a question
Top Posters
Since Sunday
5
a
5
k
5
c
5
B
5
l
5
C
4
s
4
a
4
t
4
i
4
r
4
New Topic  
Cwilliams62 Cwilliams62
wrote...
Posts: 339
Rep: 0 0
6 years ago
A nurse working in a private pediatric practice is caring for a patient who has been receiving 17alpha-alkylated androgen (Fluoxymesterone).
 
  Which clinical manifestation would cause the nurse to be concerned, and what intervention would the nurse anticipate? a. Gynecomastia; discontinuation of the drug
  b. Yellowish tint to the skin and sclera; discontinuation of the drug
  c. Decrease in high-density lipoprotein (HDL); titration of the medication
  d. Erratic blood glucose levels; adjustment of the dose
Read 33 times
1 Reply

Related Topics

Replies
wrote...
6 years ago
B
A yellowish tint to the skin and sclera would most concern the nurse, because 17alpha-alkylated androgen (Fluoxymesterone) is known to cause hepatotoxicity.
Gynecomastia is expected in males.
A decrease in HDL would require monitoring of those levels but not titration of the medication.
Fluoxymesterone is not associated with erratic blood glucose levels.
New Topic      
Explore
Post your homework questions and get free online help from our incredible volunteers
  1274 People Browsing
Related Images
  
 1325
  
 1147
  
 319
Your Opinion
Which is the best fuel for late night cramming?
Votes: 145

Previous poll results: Where do you get your textbooks?